ArticleJournal of pharmacy & bioallied sciences2025
Assessment of Efficacy of Various Anesthetic Agents in Reduction of Nausea and Vomiting Postoperatively: A Comparative Study.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: "Postoperative nausea and vomiting (PONV)" are frequent adverse effects following anesthesia, which may exert significant implications on patient postoperative recovery and comfort. Current trial aimed to compare the efficacy of Remimazolam in relation to Propofol for reducing PONV in surgical patients. Methods: A randomized controlled trial was conducted with patients scheduled for elective surgery under general anesthesia. A group of patients was given Remimazolam, and another propofol. The incidence of PONV and severity of nausea were determined, the number of episodes of vomiting were recorded, and the requirement for rescue antiemetics was also noted at 24 hours post-surgery. Results: Overall PONV incidence was significantly lower in Remimazolam group (12%) as compared to Propofol group (34%), Conclusion: Compared with Propofol, Remimazolam had the best effectiveness in PONV events, necessity of using rescue antiemetics and degree of nausea at point. These findings may indicate that Remimazolam is a more suitable anesthetic for high-risk PONV patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.